Type 2 diabetes
Showing of 1 results

Sanjay Rajagopalan, MD, Leads Clinical Trial Showing Mechanism of Benefit of Mineralocorticoid Receptor Antagonist for Patients with Type 2 Diabetes and Chronic Kidney Disease
Innovations in Cardiovascular Medicine & Surgery | Fall 2024
Results are loading...